JSPR Q1 2025 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JSPRJasper Therapeutics, Inc.

$23M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$22M

Net Income

-$21M

EPS (Diluted)

$-1.41

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$58M

Total Liabilities

$15M

Stockholders' Equity

$42M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$288,000	+100.0%
Operating Income	-$22M	-$15M	-44.7%
Net Income	-$21M	-$14M	-54.7%